BiotechTube
Home/FivepHusion/David Ranson
DR

David Ranson

Executive Chairman

FivepHusion

Therapeutic Areas

Oncology

FivepHusion Pipeline

DrugIndicationPhase
Deflexifol™Solid tumours (colorectal, pancreatic, gastric, breast) and paediatric brain cancers (ependymoma)Phase 2

Leadership Team at FivepHusion

DC
Dr. Christian Toouli
CEO & Managing Director
View full FivepHusion profile